These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9005726)

  • 21. [The effects of the short-term regular exercise-diet program on lipid profile in sedentary subjects].
    Yalin S; Gök H; Toksöz R
    Anadolu Kardiyol Derg; 2001 Sep; 1(3):179-8, AXV. PubMed ID: 12101821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet.
    Knopp RH; Retzlaff BM; Walden CE; Dowdy AA; Tsunehara CH; Austin MA; Nguyen T
    J Am Coll Nutr; 1997 Dec; 16(6):551-61. PubMed ID: 9430083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study.
    Kaitosaari T; Rönnemaa T; Raitakari O; Talvia S; Kallio K; Volanen I; Leino A; Jokinen E; Välimäki I; Viikari J; Simell O
    Circulation; 2003 Aug; 108(6):672-7. PubMed ID: 12885748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperlipidemia in children and adolescents: diagnosis and therapy].
    Koletzko B; Herzog M
    Schweiz Med Wochenschr; 1998 Mar; 128(13):477-85. PubMed ID: 9583098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.
    Kurowska EM; Jordan J; Spence JD; Wetmore S; Piché LA; Radzikowski M; Dandona P; Carroll KK
    Clin Invest Med; 1997 Jun; 20(3):162-70. PubMed ID: 9189647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.
    Ose L
    Semin Vasc Med; 2004 Feb; 4(1):51-7. PubMed ID: 15199433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of apoprotein B in the diagnosis and follow up of hyperlipoproteinemias in childhood].
    Montero Brens C; Breto Gilabert M; Dalmau Serra J
    An Esp Pediatr; 1991 Aug; 35(2):109-12. PubMed ID: 1952458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beef and soy-based food supplements differentially affect serum lipoprotein-lipid profiles because of changes in carbohydrate intake and novel nutrient intake ratios in older men who resistive-train.
    Haub MD; Wells AM; Campbell WW
    Metabolism; 2005 Jun; 54(6):769-74. PubMed ID: 15931612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY
    Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in drug treatment of dyslipidemia: focus on atorvastatin.
    Davignon J
    Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Navarra study (PECNA). Hyperlipidemia III. Variations in the median HDL levels and lipid risk quotient in children and adolescents based on age and gender].
    Elcarte López R; Villa Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzabal Irigoyen M; Sola Mateos A; García Ibero C; Martínez González A; Ferrer Giménez M; Fonteneda Estíbaliz A
    An Esp Pediatr; 1993 Mar; 38(3):198-204. PubMed ID: 8460835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study from Navarra. Hyperlipidemia V. What is the best definition of hyperlipemia in childhood and adolescence?].
    Elcarte López R; Villa Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; García Ibero C; Elcarte López T; Ferrer Giménez M; Fontaneda Estíbaliz A
    An Esp Pediatr; 1993 Apr; 38(4):317-22. PubMed ID: 8480943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Atherogenic risk factors in children of parents with ischemic heart disease].
    Mur Llorente M; Sarriá Chueca A; Lázaro Almarza A; Moreno Aznar L; Roda Altes L; Giner Soria A; Bueno Sánchez M
    An Esp Pediatr; 1993 Jun; 38(6):535-41. PubMed ID: 8368684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Navarra study (PECNA). Hyperlipidemia IV. Prevalence of hyperlipidemia in the infant- and juvenile population of Navarra. Variations based on age, gender and health care accessibility].
    Elcarte López R; Villa Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzabal Irigoyen M; Sola Mateos A; García Ibero C; Martínez González A; Ferrer Giménez M; Fontaneda Estíbaliz A
    An Esp Pediatr; 1993 Mar; 38(3):205-12. PubMed ID: 8460836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in mean serum lipid levels in pediatric and adolescent population of Navarra between 1987 and 1993].
    Iñigo Martínez J; Elcarte López R; Repáraz Abaitua F; Palau Bondía J; Landa Aristizábal V
    Rev Esp Cardiol; 1996 Mar; 49(3):166-73. PubMed ID: 8685519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Navarra study. Prevalence of arterial hypertension, hyperlipidemia and obesity in the infant-child population of Navarra. Association of risk factors].
    Elcarte López R; Villa Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; Martínez González A; Elcarte López T; Ayensa Mezquiriz I; Castiella Lafuente F
    An Esp Pediatr; 1993 May; 38(5):428-36. PubMed ID: 8503586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.